ALD Connect Hosted an In-Person Industry Advisory Council Meeting

ALD Connect hosted an in person Industry Advisory Council meeting on January 17, 2025 in Boston.

Presenters were Julie Donovan from Spur Therapeutics and Dr. Daniel Orby from Arbor Biotechnologies. Representatives from Aspen Neuroscience, bluebird bio, Rectify Pharmaceuticals, Progentos Therapeutics, Spolia Therapeutics, and Vertex Pharmaceuticals were also present. Gershon Goren shared a patient perspective. We were honored to have Joey and Tyler Hall from Will to Cure ALD present as well. Our partners from Minoryx Therapeutics and Arcadia Pharmaceuticals sent their regards.

We look forward to keeping you updated on progress this year!